VANDA PHARMACEUTICALS INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
VANDA PHARMACEUTICALS INC. (VNDA) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $200.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2019-02-19
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2018-06-30 was $0.00.
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2017-12-31 was $0.00.
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2017-09-30 was -$300.00K, a 200.00% decline year-over-year.
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2018 was $200.00K.
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2016 was $200.00K, a 0.00% change from fiscal 2015.
- VANDA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2015 was $200.00K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $200.00K 10-K · filed 2019-02-19 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | $0.00 derived: sum of 3 quarters · filed 2019-02-19 | -$300.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 | $0.00 derived: sum of 2 quarters · filed 2019-02-19 | -$300.00K derived: sum of 3 quarters · filed 2019-02-19 | -$400.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$300.00K derived: sum of 2 quarters · filed 2019-02-19 | -$400.00K derived: sum of 3 quarters · filed 2019-02-19 | $0.00 10-K · filed 2019-02-19 | |
| 2017-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$400.00K derived: sum of 2 quarters · filed 2018-08-02 | $0.00 10-Q · filed 2017-11-08 | -$100.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $300.00K 10-Q · filed 2018-08-02 | $200.00K derived: sum of 3 quarters · filed 2019-02-19 | $500.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-03-31 | $400.00K 10-Q · filed 2018-05-02 | $300.00K derived: sum of 2 quarters · filed 2019-02-19 | $600.00K derived: sum of 3 quarters · filed 2019-02-19 | $600.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2016-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $200.00K derived: sum of 2 quarters · filed 2019-02-19 | $200.00K derived: sum of 3 quarters · filed 2019-02-19 | $200.00K 10-K · filed 2019-02-19 | |
| 2016-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $300.00K derived: sum of 2 quarters · filed 2017-11-08 | $300.00K 10-Q · filed 2017-11-08 | $171.00K derived: sum of 4 quarters · filed 2018-02-15 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | -$129.00K derived: sum of 3 quarters · filed 2018-02-15 | -$559.00K derived: sum of 4 quarters · filed 2018-02-15 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-03 | -$129.00K derived: sum of 2 quarters · filed 2018-02-15 | -$559.00K derived: sum of 3 quarters · filed 2018-02-15 | ||
| 2015-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$559.00K derived: sum of 2 quarters · filed 2018-02-15 | $200.00K 10-K · filed 2018-02-15 | $187.00K 10-K · filed 2016-02-12 | |
| 2015-09-30 | -$430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $329.00K 10-Q · filed 2015-11-04 | |||
| 2015-06-30 | $759.00K 10-Q · filed 2015-07-31 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-02-17 | ||||
| 2014-06-30 | $20.00K 10-Q · filed 2015-07-31 | ||||
| 2013-12-31 | $106.00K 10-K · filed 2016-02-12 | ||||
| 2011-12-31 | $221.00K 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |